OMB Directs Agencies to Prepare for Sequestration
Client Alert | less than 1 min read | 12.12.12
OMB has recently issued internal guidance directing agencies to begin preparing for sequestration, prompting numerous agencies to reveal their intent to furlough employees, reduce office hours, and scale back or eliminate contracts should budget cuts occur as scheduled in January 2013. While the White House denied that the guidance signals pessimism about a budget deal, and events over the weekend suggest that the broad outlines of an agreement are coming together, the release of the guidance nonetheless recognizes that the time remaining for negotiating a resolution to avoid sequestration is growing short.
Contacts
Insights
Client Alert | 9 min read | 10.21.26
The life sciences sector is uniquely vulnerable to the inherent risks of AI-generated evidence in drug development and discovery. This client alert focuses on five core challenges: hallucinations, skewed predictions from unrepresentative training data, the opacity of AI reasoning, input sensitivity that undermines reproducibility, and adversarial manipulation of training data. To address these risks, companies should use experimental validation and human oversight as the common legal and regulatory safety net. This entails among other measures auditing AI outputs, characterizing training data, and structural oversight. Companies also should prepare for evolving frameworks and guidance from the U.S. Food and Drug Administration (FDA) and the European Union (EU) that address use of AI in drug discovery and development .
Client Alert | 2 min read | 10.21.26
Client Alert | 3 min read | 10.21.26
Private Investigations Act Series: Temporal, material and territorial scope
Client Alert | 7 min read | 10.21.26
